Delay  ||| S:0 E:6 ||| NN
in  ||| S:6 E:9 ||| IN
the  ||| S:9 E:13 ||| DT
diagnosis  ||| S:13 E:23 ||| NN
of  ||| S:23 E:26 ||| IN
multiple  ||| S:26 E:35 ||| JJ
sclerosis  ||| S:35 E:45 ||| NN
in  ||| S:45 E:48 ||| IN
Croatia  ||| S:48 E:56 ||| NNP
The  ||| S:56 E:60 ||| NNP
National  ||| S:60 E:69 ||| NNP
Institute  ||| S:69 E:79 ||| NNP
for  ||| S:79 E:83 ||| IN
Health  ||| S:83 E:90 ||| NNP
and  ||| S:90 E:94 ||| CC
Clinical  ||| S:94 E:103 ||| NNP
Excellence  ||| S:103 E:114 ||| NNP
( ||| S:114 E:115 ||| -LRB-
NICE ||| S:115 E:119 ||| NNP
)  ||| S:119 E:121 ||| -RRB-
guidelines  ||| S:121 E:132 ||| NNS
for  ||| S:132 E:136 ||| IN
multiple  ||| S:136 E:145 ||| JJ
sclerosis  ||| S:145 E:155 ||| NNS
( ||| S:155 E:156 ||| -LRB-
MS ||| S:156 E:158 ||| NNP
)  ||| S:158 E:160 ||| -RRB-
recommend  ||| S:160 E:170 ||| VB
the  ||| S:170 E:174 ||| DT
time  ||| S:174 E:179 ||| NN
from  ||| S:179 E:184 ||| IN
initial  ||| S:184 E:192 ||| JJ
presentation  ||| S:192 E:205 ||| NN
to  ||| S:205 E:208 ||| TO
first  ||| S:208 E:214 ||| JJ
neurological  ||| S:214 E:227 ||| JJ
evaluation  ||| S:227 E:238 ||| NN
to  ||| S:238 E:241 ||| TO
be  ||| S:241 E:244 ||| VB
no  ||| S:244 E:247 ||| DT
longer  ||| S:247 E:254 ||| JJR
than  ||| S:254 E:259 ||| IN
6  ||| S:259 E:261 ||| CD
weeks ||| S:261 E:266 ||| NNS
,  ||| S:266 E:268 ||| ,
and  ||| S:268 E:272 ||| CC
a  ||| S:272 E:274 ||| DT
further  ||| S:274 E:282 ||| JJ
6  ||| S:282 E:284 ||| CD
weeks  ||| S:284 E:290 ||| NNS
until  ||| S:290 E:296 ||| IN
any  ||| S:296 E:300 ||| DT
necessary  ||| S:300 E:310 ||| JJ
investigations  ||| S:310 E:325 ||| NNS
are  ||| S:325 E:329 ||| VBP
completed ||| S:329 E:338 ||| VBN
.  ||| S:338 E:340 ||| .
The  ||| S:340 E:344 ||| DT
aim  ||| S:344 E:348 ||| NN
of  ||| S:348 E:351 ||| IN
this  ||| S:351 E:356 ||| DT
study  ||| S:356 E:362 ||| NN
was  ||| S:362 E:366 ||| VBD
to  ||| S:366 E:369 ||| TO
evaluate  ||| S:369 E:378 ||| VB
how  ||| S:378 E:382 ||| WRB
many  ||| S:382 E:387 ||| JJ
patients  ||| S:387 E:396 ||| NNS
with  ||| S:396 E:401 ||| IN
MS  ||| S:401 E:404 ||| NNP
are  ||| S:404 E:408 ||| VBP
diagnosed  ||| S:408 E:418 ||| VBN
within  ||| S:418 E:425 ||| IN
the  ||| S:425 E:429 ||| DT
NICE  ||| S:429 E:434 ||| NNP
timelines  ||| S:434 E:444 ||| NN
in  ||| S:444 E:447 ||| IN
two  ||| S:447 E:451 ||| CD
settings  ||| S:451 E:460 ||| NNS
specific  ||| S:460 E:469 ||| JJ
for  ||| S:469 E:473 ||| IN
Croatia ||| S:473 E:480 ||| NNP
.  ||| S:480 E:482 ||| .
All  ||| S:482 E:486 ||| DT
patients  ||| S:486 E:495 ||| NNS
with  ||| S:495 E:500 ||| IN
the  ||| S:500 E:504 ||| DT
final  ||| S:504 E:510 ||| JJ
diagnosis  ||| S:510 E:520 ||| NN
of  ||| S:520 E:523 ||| IN
clinically  ||| S:523 E:534 ||| JJ
isolated  ||| S:534 E:543 ||| JJ
syndrome  ||| S:543 E:552 ||| NN
( ||| S:552 E:553 ||| -LRB-
CIS ||| S:553 E:556 ||| NNP
)  ||| S:556 E:558 ||| -RRB-
or  ||| S:558 E:561 ||| CC
MS  ||| S:561 E:564 ||| NNP
in  ||| S:564 E:567 ||| IN
a  ||| S:567 E:569 ||| DT
6  ||| S:569 E:571 ||| CD
months  ||| S:571 E:578 ||| NNS
period  ||| S:578 E:585 ||| NN
were  ||| S:585 E:590 ||| VBD
retrospectively  ||| S:590 E:606 ||| VBN
reviewed ||| S:606 E:614 ||| VBN
.  ||| S:614 E:616 ||| .
We  ||| S:616 E:619 ||| PRP
calculated  ||| S:619 E:630 ||| VBD
time  ||| S:630 E:635 ||| NN
from  ||| S:635 E:640 ||| IN
first  ||| S:640 E:646 ||| JJ
symptom  ||| S:646 E:654 ||| NN
to  ||| S:654 E:657 ||| TO
first  ||| S:657 E:663 ||| JJ
neurological  ||| S:663 E:676 ||| JJ
evaluation ||| S:676 E:686 ||| NN
,  ||| S:686 E:688 ||| ,
time  ||| S:688 E:693 ||| NN
from  ||| S:693 E:698 ||| IN
first  ||| S:698 E:704 ||| JJ
symptom  ||| S:704 E:712 ||| NN
to  ||| S:712 E:715 ||| TO
MRI  ||| S:715 E:719 ||| NNP
scan ||| S:719 E:723 ||| NN
,  ||| S:723 E:725 ||| ,
time  ||| S:725 E:730 ||| NN
from  ||| S:730 E:735 ||| IN
first  ||| S:735 E:741 ||| JJ
neurological  ||| S:741 E:754 ||| JJ
evaluation  ||| S:754 E:765 ||| NN
to  ||| S:765 E:768 ||| TO
MRI  ||| S:768 E:772 ||| NNP
scan ||| S:772 E:776 ||| NN
,  ||| S:776 E:778 ||| ,
time  ||| S:778 E:783 ||| NN
from  ||| S:783 E:788 ||| IN
first  ||| S:788 E:794 ||| JJ
neurological  ||| S:794 E:807 ||| JJ
evaluation  ||| S:807 E:818 ||| NN
to  ||| S:818 E:821 ||| TO
lumbar  ||| S:821 E:828 ||| VB
puncture  ||| S:828 E:837 ||| NNS
( ||| S:837 E:838 ||| -LRB-
LP ||| S:838 E:840 ||| NNP
) ||| S:840 E:841 ||| -RRB-
,  ||| S:841 E:843 ||| ,
time  ||| S:843 E:848 ||| NN
from  ||| S:848 E:853 ||| IN
first  ||| S:853 E:859 ||| JJ
symptom  ||| S:859 E:867 ||| NN
to  ||| S:867 E:870 ||| TO
diagnosis  ||| S:870 E:880 ||| NN
and  ||| S:880 E:884 ||| CC
time  ||| S:884 E:889 ||| NN
from  ||| S:889 E:894 ||| IN
first  ||| S:894 E:900 ||| JJ
neurological  ||| S:900 E:913 ||| JJ
evaluation  ||| S:913 E:924 ||| NN
to  ||| S:924 E:927 ||| TO
diagnosis ||| S:927 E:936 ||| NN
.  ||| S:936 E:938 ||| .
We  ||| S:938 E:941 ||| PRP
also  ||| S:941 E:946 ||| RB
calculated  ||| S:946 E:957 ||| VBN
the  ||| S:957 E:961 ||| DT
percentage  ||| S:961 E:972 ||| NN
of  ||| S:972 E:975 ||| IN
patients  ||| S:975 E:984 ||| NNS
fulfilling  ||| S:984 E:995 ||| VBG
the  ||| S:995 E:999 ||| DT
NICE  ||| S:999 E:1004 ||| NNP
timelines ||| S:1004 E:1013 ||| NN
.  ||| S:1013 E:1015 ||| .
This  ||| S:1015 E:1020 ||| DT
study  ||| S:1020 E:1026 ||| NN
showed  ||| S:1026 E:1033 ||| VBD
that  ||| S:1033 E:1038 ||| IN
only  ||| S:1038 E:1043 ||| RB
61.5 ||| S:1043 E:1047 ||| CD
%  ||| S:1047 E:1049 ||| NN
of  ||| S:1049 E:1052 ||| IN
MS  ||| S:1052 E:1055 ||| NNP
patients  ||| S:1055 E:1064 ||| NNS
in  ||| S:1064 E:1067 ||| IN
Croatia  ||| S:1067 E:1075 ||| NNP
see  ||| S:1075 E:1079 ||| VBP
neurologist  ||| S:1079 E:1091 ||| VBN
within  ||| S:1091 E:1098 ||| IN
6  ||| S:1098 E:1100 ||| CD
weeks  ||| S:1100 E:1106 ||| NNS
of  ||| S:1106 E:1109 ||| IN
first  ||| S:1109 E:1115 ||| JJ
symptoms ||| S:1115 E:1123 ||| NNS
,  ||| S:1123 E:1125 ||| ,
and  ||| S:1125 E:1129 ||| CC
64.1 ||| S:1129 E:1133 ||| CD
%  ||| S:1133 E:1135 ||| NN
are  ||| S:1135 E:1139 ||| VBP
diagnosed  ||| S:1139 E:1149 ||| VBN
within  ||| S:1149 E:1156 ||| IN
next  ||| S:1156 E:1161 ||| JJ
6  ||| S:1161 E:1163 ||| CD
weeks ||| S:1163 E:1168 ||| NNS
.  ||| S:1168 E:1170 ||| .
However ||| S:1170 E:1177 ||| RB
,  ||| S:1177 E:1179 ||| ,
80 ||| S:1179 E:1181 ||| CD
%  ||| S:1181 E:1183 ||| NN
and  ||| S:1183 E:1187 ||| CC
100 ||| S:1187 E:1190 ||| CD
%  ||| S:1190 E:1192 ||| NN
of  ||| S:1192 E:1195 ||| IN
patients  ||| S:1195 E:1204 ||| NNS
presented  ||| S:1204 E:1214 ||| VBN
to  ||| S:1214 E:1217 ||| TO
the  ||| S:1217 E:1221 ||| DT
emergency  ||| S:1221 E:1231 ||| NN
room  ||| S:1231 E:1236 ||| NN
of  ||| S:1236 E:1239 ||| IN
our  ||| S:1239 E:1243 ||| PRP$
hospital  ||| S:1243 E:1252 ||| NN
( ||| S:1252 E:1253 ||| -LRB-
where  ||| S:1253 E:1259 ||| WRB
a  ||| S:1259 E:1261 ||| DT
visit  ||| S:1261 E:1267 ||| NN
to  ||| S:1267 E:1270 ||| TO
a  ||| S:1270 E:1272 ||| DT
MS  ||| S:1272 E:1275 ||| NNP
clinic  ||| S:1275 E:1282 ||| NN
can  ||| S:1282 E:1286 ||| MD
be  ||| S:1286 E:1289 ||| VB
automatically  ||| S:1289 E:1303 ||| RB
made ||| S:1303 E:1307 ||| VBN
)  ||| S:1307 E:1309 ||| -RRB-
met  ||| S:1309 E:1313 ||| VBD
the  ||| S:1313 E:1317 ||| DT
NICE  ||| S:1317 E:1322 ||| NNP
guidelines  ||| S:1322 E:1333 ||| NNS
for  ||| S:1333 E:1337 ||| IN
time  ||| S:1337 E:1342 ||| NN
from  ||| S:1342 E:1347 ||| IN
first  ||| S:1347 E:1353 ||| JJ
symptom  ||| S:1353 E:1361 ||| NN
to  ||| S:1361 E:1364 ||| TO
first  ||| S:1364 E:1370 ||| JJ
neurological  ||| S:1370 E:1383 ||| JJ
evaluation  ||| S:1383 E:1394 ||| NN
and  ||| S:1394 E:1398 ||| CC
time  ||| S:1398 E:1403 ||| NN
from  ||| S:1403 E:1408 ||| IN
first  ||| S:1408 E:1414 ||| JJ
neurological  ||| S:1414 E:1427 ||| JJ
evaluation  ||| S:1427 E:1438 ||| NN
to  ||| S:1438 E:1441 ||| TO
diagnosis ||| S:1441 E:1450 ||| NN
,  ||| S:1450 E:1452 ||| ,
respectively ||| S:1452 E:1464 ||| RB
.  ||| S:1464 E:1466 ||| .
A  ||| S:1466 E:1468 ||| DT
specifically  ||| S:1468 E:1481 ||| RB
designed  ||| S:1481 E:1490 ||| VBN
demyelinating  ||| S:1490 E:1504 ||| JJ
disease  ||| S:1504 E:1512 ||| NN
diagnostic  ||| S:1512 E:1523 ||| JJ
clinic  ||| S:1523 E:1530 ||| NN
offers  ||| S:1530 E:1537 ||| VBZ
a  ||| S:1537 E:1539 ||| DT
better  ||| S:1539 E:1546 ||| JJR
service  ||| S:1546 E:1554 ||| NN
than  ||| S:1554 E:1559 ||| IN
other  ||| S:1559 E:1565 ||| JJ
existing  ||| S:1565 E:1574 ||| JJ
models  ||| S:1574 E:1581 ||| NNS
in  ||| S:1581 E:1584 ||| IN
the  ||| S:1584 E:1588 ||| DT
diagnosis  ||| S:1588 E:1598 ||| NN
and  ||| S:1598 E:1602 ||| CC
management  ||| S:1602 E:1613 ||| NN
of  ||| S:1613 E:1616 ||| IN
MS  ||| S:1616 E:1619 ||| NNP
patients ||| S:1619 E:1627 ||| NNS
.  ||| S:1627 E:1629 ||| .
